Framework shuffling of antibodies to reduce immunogenicity and manipulate functional and biophysical properties

被引:30
作者
Damschroder, Melissa M.
Widjaja, Lusiana
Gill, Parkash S.
Krasnoperov, Valery
Jiang, Weidong
Dall'Acqua, William F.
Wu, Herren
机构
[1] Medimmune Inc, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA
[2] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90089 USA
[3] Vasgene Therapeut Inc, Los Angeles, CA 90033 USA
关键词
antibody; humanization; affinity; thermostability; expression; isoelectric point;
D O I
10.1016/j.molimm.2006.12.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report here the humanization of two mouse monoclonal antibodies (mAb) using framework shuffling of human germline genes. mAbs EA2 and 47 were raised against the human receptor tyrosine kinase EphA2 and EphB4, respectively, which exhibit increased expression levels in many cancer cell lines. One- and two-step strategies were carried out, in which the light and heavy chains of each parental mAb were simultaneously or sequentially humanized. We characterized in detail these newly humanized antibodies in terms of binding affinity to their respective antigen, functional activity, thermostability, electric charge and expression yields. Three previously described framework shuffled, humanized versions of another mouse anti-human EphA2 antibody (mAb B233) were similarly characterized. We show that several of these parameters were either maintained or improved in all humanized molecules when compared with their respective chimaeric counterpart. Therefore, this humanization approach is generally applicable to non-human IgGs and allows for the specific selection of antibodies and antibody fragments exhibiting favorable functional, biochemical and biophysical properties. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3049 / 3060
页数:12
相关论文
共 54 条
[1]   Generation of a highly stable, internalizing anti-CD22 single-chain Fv fragment for targeting non-Hodgkin's lymphoma [J].
Arndt, MAE ;
Krauss, J ;
Schwarzenbacher, R ;
Vu, BK ;
Greene, S ;
Rybak, SM .
INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (05) :822-829
[2]   RAPID HUMANIZATION OF THE FV OF MONOCLONAL-ANTIBODY B3 BY USING FRAMEWORK EXCHANGE OF THE RECOMBINANT IMMUNOTOXIN B3(FV)-PE38 [J].
BENHAR, I ;
PADLAN, EA ;
JUNG, SH ;
LEE, B ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (25) :12051-12055
[3]   A VERY STRONG ENHANCER IS LOCATED UPSTREAM OF AN IMMEDIATE EARLY GENE OF HUMAN CYTOMEGALO-VIRUS [J].
BOSHART, M ;
WEBER, F ;
JAHN, G ;
DORSCHHASLER, K ;
FLECKENSTEIN, B ;
SCHAFFNER, W .
CELL, 1985, 41 (02) :521-530
[4]  
Carles-Kinch K, 2002, CANCER RES, V62, P2840
[5]  
CLELAND JL, 1993, CRIT REV THER DRUG, V10, P307
[6]  
Coffman KT, 2003, CANCER RES, V63, P7907
[7]   Antibody humanization by framework shuffling [J].
Dall'Acqua, WF ;
Damschroder, MM ;
Zhang, JL ;
Woods, RM ;
Widjaja, L ;
Yu, J ;
Wu, H .
METHODS, 2005, 36 (01) :43-60
[8]   Effects of humanization by variable domain resurfacing on the antiviral activity of a single-chain antibody against respiratory syncytial virus [J].
Delagrave, S ;
Catalan, J ;
Sweet, C ;
Drabik, G ;
Henry, A ;
Rees, A ;
Monath, TP ;
Guirakhoo, F .
PROTEIN ENGINEERING, 1999, 12 (04) :357-362
[9]   Engineering stability into Escherichia coli secreted Fabs leads to increased functional expression [J].
Demarest, Stephen J. ;
Chen, Gang ;
Kimmel, Bruce E. ;
Gustafson, David ;
Wu, Jane ;
Salbato, Jared ;
Poland, John ;
Elia, Marikka ;
Tan, Xuqiu ;
Wong, Ken ;
Short, Jay ;
Hansen, Genevieve .
PROTEIN ENGINEERING DESIGN & SELECTION, 2006, 19 (07) :325-336
[10]   Stability improvement of antibodies for extracellular and intracellular applications:: CDR grafting to stable frameworks and structure-based framework engineering [J].
Ewert, S ;
Honegger, A ;
Plückthun, A .
METHODS, 2004, 34 (02) :184-199